CNTB (Connect Biopharma Holdings) EPS without NRI: $-1.15 (TTM As of Mar. 2026)


CNTB Connect Biopharma Holdings Ltd CNTB
7 GF Score
Price $2.25
! 3 Warning Signs
View Full Analysis

What is Connect Biopharma Holdings EPS without NRI?

Connect Biopharma Holdings CNTB -4.66% 7 EPS without NRI is $-1.15 as of Mar. 2026. GuruFocus rates CNTB with a GF Score™ of 7/100. The stock has 3 warning signs investors should review. Among 1,166 Biotechnology companies, Connect Biopharma Holdings ranks better than 57.03% on this metric.

Connect Biopharma Holdings's earnings per share without non-recurring items for the three months ended in Mar. 2026 was $-0.34. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.15.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 22.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 11.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Connect Biopharma Holdings's EPS without NRI or its related term are showing as below:

CNTB' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -93.7   Med: -2.55   Max: 51.3
Current: 22

During the past 7 years, Connect Biopharma Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 51.30% per year. The lowest was -93.70% per year. And the median was -2.55% per year.

CNTB's 3-Year EPS without NRI Growth Rate is ranked better than
57.03% of 1166 companies
in the Biotechnology industry
Industry Median: 16.65 vs CNTB: 22.00

Connect Biopharma Holdings's EPS (Diluted) for the three months ended in Mar. 2026 was $-0.34. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.15.

Connect Biopharma Holdings's EPS (Basic) for the three months ended in Mar. 2026 was $-0.34. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.15.


Connect Biopharma Holdings  (NAS:CNTB) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Connect Biopharma Holdings EPS without NRI Related Terms


Connect Biopharma Holdings EPS without NRI Historical Data

* Premium members only.

The historical data trend for Connect Biopharma Holdings's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Connect Biopharma Holdings EPS without NRI Chart

Connect Biopharma Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial -2.42 -2.11 -1.13 -0.28 -1.00

Connect Biopharma Holdings Quarterly Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.23 -0.31 -0.27 -0.34

CNTB vs ENLV, SMNR, MENS: EPS without NRI Comparison

For the Biotechnology subindustry, Connect Biopharma Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Connect Biopharma Holdings PE Ratio without NRI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Connect Biopharma Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Connect Biopharma Holdings's PE Ratio without NRI falls into.


CNTB
7GF Score
Connect Biopharma Holdings Ltd CNTB
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Connect Biopharma Holdings EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $-1.15 mean?
Connect Biopharma Holdings (CNTB) has a EPS without NRI of $-1.15 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Connect Biopharma Holdings and its competitors. According to the industry distribution chart, Connect Biopharma Holdings ranks #501 out of 1166 companies in the Biotechnology industry, placing it in the top 43%.
Is Connect Biopharma Holdings' EPS without NRI too high?
Connect Biopharma Holdings' current EPS without NRI is $-1.15. Based on the distribution chart, Connect Biopharma Holdings ranks #501 out of 1166 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Connect Biopharma Holdings has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Connect Biopharma Holdings' EPS without NRI compare to ENLV and SMNR?
According to the Biotechnology industry distribution chart, Connect Biopharma Holdings ranks #501 out of 1166 companies for EPS without NRI. This puts Connect Biopharma Holdings in the upper half of its industry. The industry median EPS without NRI is 16.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Biotechnology company?
The median EPS without NRI among Biotechnology companies is 16.65, based on 1,166 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Connect Biopharma Holdings and its competitors. For the Biotechnology industry, the median EPS without NRI is 16.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Connect Biopharma Holdings's current EPS without NRI is $-1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Connect Biopharma Holdings stock overvalued right now?
Connect Biopharma Holdings (CNTB) has a current EPS without NRI of $-1.15. The current EPS without NRI is $-1.15. Connect Biopharma Holdings' overall GF Score™ is 7/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Connect Biopharma Holdings (CNTB), the current EPS without NRI is $-1.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Connect Biopharma Holdings Business Description

Address 3580 Carmel Mountain Road, Suite 200, San Diego, CA, USA, 92130
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
7GF Score

Get the complete analysis for CNTB

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.25
Price